Works matching IS 15228517 AND DT 2018 AND VI 20 AND IP 10

Results: 18

Volumetric response quantified using T1 subtraction predicts long-term survival benefit from cabozantinib monotherapy in recurrent glioblastoma.

Published in:

Neuro-Oncology, 2018, v. 20, n. 10, p. 1411, doi. 10.1093/neuonc/noy054

By:

Ellingson, Benjamin M;
Aftab, Dana T;
Schwab, Gisela M;
Hessel, Colin;
Harris, Robert J;
Woodworth, Davis C;
Leu, Kevin;
Chakhoyan, Ararat;
Raymond, Catalina;
Drappatz, Jan

Publication type:

Article

The TNF receptor family member Fn14 is highly expressed in recurrent glioblastoma and in GBM patient-derived xenografts with acquired temozolomide resistance.

Published in:

Neuro-Oncology, 2018, v. 20, n. 10, p. 1321, doi. 10.1093/neuonc/noy063

By:

Hersh, David S;
Harder, Bryan G;
Roos, Alison;
Peng, Sen;
Heath, Jonathan E;
Legesse, Teklu;
Kim, Anthony J;
Woodworth, Graeme F;
Tran, Nhan L;
Winkles, Jeffrey A

Publication type:

Article

Temozolomide-associated hypermutation in gliomas.

Published in:

Neuro-Oncology, 2018, v. 20, n. 10, p. 1300, doi. 10.1093/neuonc/noy016

By:

Choi, Serah;
Yu, Yao;
Grimmer, Matthew R;
Wahl, Michael;
Chang, Susan M;
Costello, Joseph F

Publication type:

Article

The T2-FLAIR mismatch sign as an imaging marker for non-enhancing IDH-mutant, 1p/19q-intact lower-grade glioma: a validation study.

Published in:

Neuro-Oncology, 2018, v. 20, n. 10, p. 1393, doi. 10.1093/neuonc/noy048

By:

Broen, Martinus P G;
Smits, Marion;
Wijnenga, Maarten M J;
Dubbink, Hendrikus J;
Anten, Monique H M E;
Schijns, Olaf E M G;
Beckervordersandforth, Jan;
Postma, Alida A;
Bent, Martin J van den

Publication type:

Article

Prognostic value of contrast enhancement and FLAIR for survival in newly diagnosed glioblastoma treated with and without bevacizumab: results from ACRIN 6686.

Published in:

Neuro-Oncology, 2018, v. 20, n. 10, p. 1400, doi. 10.1093/neuonc/noy049

By:

Boxerman, Jerrold L;
Zhang, Zheng;
Safriel, Yair;
Rogg, Jeffrey M;
Wolf, Ronald L;
Mohan, Suyash;
Marques, Helga;
Sorensen, A Gregory;
Gilbert, Mark R;
Barboriak, Daniel P

Publication type:

Article

PI3K activation in neural stem cells drives tumorigenesis which can be ameliorated by targeting the cAMP response element binding protein.

Published in:

Neuro-Oncology, 2018, v. 20, n. 10, p. 1344, doi. 10.1093/neuonc/noy068

By:

Daniel, Paul M;
Filiz, Gulay;
Brown, Daniel V;
Christie, Michael;
Waring, Paul M;
Zhang, Yi;
Haynes, John M;
Pouton, Colin;
Flanagan, Dustin;
Vincan, Elizabeth

Publication type:

Article

Molecular ablation of tumor blood vessels inhibits therapeutic effects of radiation and bevacizumab.

Published in:

Neuro-Oncology, 2018, v. 20, n. 10, p. 1356, doi. 10.1093/neuonc/noy055

By:

Yadav, Viveka Nand;
Altshuler, David;
Kadiyala, Padma;
Zamler, Daniel;
Comba, Andrea;
Appelman, Henry;
Dunn, Patrick;
Koschmann, Carl;
Castro, Maria G;
Löwenstein, Pedro R

Publication type:

Article

Meningioma transcription factors link cell lineage with systemic metabolic cues.

Published in:

Neuro-Oncology, 2018, v. 20, n. 10, p. 1331, doi. 10.1093/neuonc/noy057

By:

Du, Ziming;
Brewster, Ryan;
Merrill, Parker H;
Chmielecki, Juliann;
Francis, Josh;
Aizer, Ayal;
Abedalthagafi, Malak;
Sholl, Lynette M;
Geffers, Lars;
Alexander, Brian

Publication type:

Article

Mapping of genomic EGFRvIII deletions in glioblastoma: insight into rearrangement mechanisms and biomarker development.

Published in:

Neuro-Oncology, 2018, v. 20, n. 10, p. 1310, doi. 10.1093/neuonc/noy058

By:

Koga, Tomoyuki;
Li, Bin;
Figueroa, Javier M;
Ren, Bing;
Chen, Clark C;
Carter, Bob S;
Furnari, Frank B

Publication type:

Article

Insurance correlates with improved access to care and outcome among glioblastoma patients.

Published in:

Neuro-Oncology, 2018, v. 20, n. 10, p. 1374, doi. 10.1093/neuonc/noy102

By:

Brown, Desmond A;
Himes, Benjamin T;
Kerezoudis, Panagiotis;
Chilinda-Salter, Yirengah M;
Grewal, Sanjeet S;
Spear, Joshua A;
Bydon, Mohamad;
Burns, Terry C;
Parney, Ian F

Publication type:

Article

Inclusion bias of patients with genetically different glioblastoma subgroups in clinical trials.

Published in:

Neuro-Oncology, 2018, v. 20, n. 10, p. 1285, doi. 10.1093/neuonc/noy112

By:

Hartmann, Christian

Publication type:

Article

Highlights from the Literature.

Published in:

Neuro-Oncology, 2018, v. 20, n. 10, p. 1289, doi. 10.1093/neuonc/noy141

By:

Wick, Wolfgang;
Soffietti, Riccardo;
Bhat, Krishna;
Abounader, Roger;
Pope, Whitney

Publication type:

Article

Health insurance and the ongoing debate of quality and quantity.

Published in:

Neuro-Oncology, 2018, v. 20, n. 10, p. 1287, doi. 10.1093/neuonc/noy121

By:

Cavaliere, Robert

Publication type:

Article

Forthcoming Meetings.

Published in:: Neuro-Oncology, 2018, v. 20, n. 10, p. 1419, doi. 10.1093/neuonc/noy140
Publication type:: Article

First results on the DCVax phase III trial: raising more questions than providing answers.

Published in:

Neuro-Oncology, 2018, v. 20, n. 10, p. 1283, doi. 10.1093/neuonc/noy125

By:

Wick, Wolfgang;
Bent, Martin J van den

Publication type:

Article

Durable complete responses in some recurrent high-grade glioma patients treated with Toca 511 + Toca FC.

Published in:

Neuro-Oncology, 2018, v. 20, n. 10, p. 1383, doi. 10.1093/neuonc/noy075

By:

Cloughesy, Timothy F;
Landolfi, Joseph;
Vogelbaum, Michael A;
Ostertag, Derek;
Elder, James B;
Bloomfield, Stephen;
Carter, Bob;
Chen, Clark C;
Kalkanis, Steven N;
Kesari, Santosh

Publication type:

Article

Copy number profiling across glioblastoma populations has implications for clinical trial design.

Published in:

Neuro-Oncology, 2018, v. 20, n. 10, p. 1368, doi. 10.1093/neuonc/noy108

By:

Cimino, Patrick J;
McFerrin, Lisa;
Wirsching, Hans-Georg;
Arora, Sonali;
Bolouri, Hamid;
Rabadan, Raul;
Weller, Michael;
Holland, Eric C

Publication type:

Article

An active role for neurons in glioma progression: making sense of Scherer’s structures.

Published in:

Neuro-Oncology, 2018, v. 20, n. 10, p. 1292, doi. 10.1093/neuonc/noy083

By:

Gillespie, Shawn;
Monje, Michelle

Publication type:

Article